Shutting Down Domain Names Tied to Illegal Online Pharmacies Can Protect Patients, NABP Report Finds
MOUNT PROSPECT, IL – The National Association of Boards of Pharmacy® (NABP®) has released a new report, Disrupting Illegal Online Pharmacies: Lock-and-Suspend as a Tool to Protect Patients, which explores the process and impact of locking and suspending domain names associated with websites that illegally sell prescription medications online. The report explains how lock-and-suspend directly […]
Read More ›NABP Enters Final Development Phase of DSCSA Interoperability Network
New Network Provides Regulators, Industry With Tool to Further Protect Drug Supply Chain MOUNT PROSPECT, IL – The National Association of Boards of Pharmacy® (NABP®) announced today that it is entering the final phase of development for its new network to facilitate supply chain interoperability. The network will provide a means for state regulators and […]
Read More ›NABP Specialty Pharmacy Accreditation Earns Optum Rx Network Recognition
The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that its Specialty Pharmacy Accreditation has earned recognition from Optum Rx’s Specialty Pharmacy Network. This recognition deems NABP as an approved accrediting organization for pharmacies seeking specialty accreditation to qualify for participation in the Optum Rx Specialty Pharmacy Network. NABP’s Specialty Pharmacy Accreditation […]
Read More ›NABP Joins Other Regulatory Associations In Launching Opioid Regulatory Collaborative
NABP and three other state board associations, have launched the Opioid Regulatory Collaborative (ORC). The ORC will bring together senior leaders from NABP, the American Association of Dental Boards, the Federation of State Medical Boards, and the National Council of State Boards of Nursing to share resources and strategies to slow opioid substance use disorder […]
Read More ›NABP Launches Compounding Pharmacy Information-Sharing Project With FDA
In June 2020, the National Association of Boards of Pharmacy (NABP) began to further develop a system to gather and share compounding pharmacy information as part of a three-year pilot project with Food and Drug Administration (FDA). Funded by FDA, this project builds upon the existing NABP e-Profile system with the addition of data fields and functionality […]
Read More ›NABP Urges Passage of the Mainstreaming Addiction Treatment Act by 117th Congress
The National Association of Boards of Pharmacy® (NABP®) continues its call for the passage of the Mainstreaming Addiction Treatment Act to remove barriers that prevent those with opioid use disorder (OUD) from accessing vital, lifesaving addiction treatment. This bipartisan bill was introduced today by Representatives Paul Tonko (D-NY), Michael Turner (R-OH), Antonio Delgado (D-NY), Anthony Gonzalez […]
Read More ›New NABP Report Explores How Pharmacists Can Safeguard Patients From Risky Dietary Supplements
In the National Association of Boards of Pharmacy® (NABP®) January 2021 Rogue Rx Activity Report, the association focuses on the risk of tainted dietary supplements to consumers. The report, titled Risky Dietary Supplements: How Pharmacists Can Help Protect Patients, explores adulterated dietary supplements that enter the marketplace and how pharmacists are well-positioned to provide consumers with information […]
Read More ›NABP Urges Congressional Leaders to Continue Supporting Federal Programs to Combat Both Opioid Epidemic and COVID-19
Emphasizing the role that pharmacists and state boards of pharmacy play in protecting the public health, NABP has sent a letter to congressional leadership urging Congress to continue supporting robust investments in federal programs to combat both the ongoing opioid epidemic and coronavirus disease 2019 (COVID-19) pandemic. Signed by NABP Executive Director/Secretary Lemrey “Al” Carter, […]
Read More ›Four-Month Pilot Aims to Address Illegal Online Opioid Sales
Written by: Matthew Rubin and Libby Baney, Faegre Drinker Consulting On June 8, 2020, Food and Drug Administration (FDA) and Department of Commerce’s National Telecommunications and Information Administration (NTIA) formally announced the formation of a 120-day pilot program targeting the illegal advertisement and sale of prescription opioids and illicit narcotics online. This announcement builds upon […]
Read More ›Global COVID-19 Threats Persist as Online Fraud and Theft Continue
Written by: Matthew Rubin, Faegre Drinker Consulting Now more than two months into the United States’ public health emergency for the coronavirus disease 2019 (COVID-19) pandemic, consumer behavior and related commerce have changed drastically. Stay-in-place orders, social distancing practices, and self-imposed quarantines have left hundreds of millions of Americans – and billions more globally – […]
Read More ›